Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(3.36)
# 1,111
Out of 5,112 analysts
56
Total ratings
43.14%
Success rate
6.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma | Upgrades: Buy | $20 → $45 | $33.61 | +33.89% | 2 | Dec 9, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $90 | $65.37 | +37.68% | 4 | Nov 28, 2025 | |
| MGTX MeiraGTx Holdings | Initiates: Buy | $20 | $7.89 | +153.49% | 1 | Nov 24, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $30 | $7.44 | +303.23% | 1 | Nov 19, 2025 | |
| NGNE Neurogene | Maintains: Buy | $65 → $70 | $19.28 | +263.07% | 3 | Nov 13, 2025 | |
| KRRO Korro Bio | Downgrades: Neutral | n/a | $7.94 | - | 2 | Nov 13, 2025 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $5 → $10 | $3.97 | +152.21% | 1 | Nov 11, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $18 → $15 | $8.93 | +67.97% | 5 | Nov 10, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $100 → $110 | $77.57 | +41.81% | 6 | Nov 10, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Neutral | $60 → $55 | $52.05 | +5.67% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $6.88 | +190.70% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $28.45 | +40.60% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $13 | $9.67 | +34.44% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $40 | $17.23 | +132.15% | 6 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $60 | $21.36 | +180.90% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $55.39 | +44.43% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $19.46 | +28.47% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $11.03 | +1,033.79% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.36 | +111.86% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $13.05 | +91.57% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $5 | $20.84 | -76.01% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $22.68 | +32.28% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.69 | +314.20% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $4.37 | -54.23% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $11.03 | +26.93% | 1 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.20 | +233.33% | 1 | Aug 11, 2025 |
Lyell Immunopharma
Dec 9, 2025
Upgrades: Buy
Price Target: $20 → $45
Current: $33.61
Upside: +33.89%
Halozyme Therapeutics
Nov 28, 2025
Reiterates: Buy
Price Target: $90
Current: $65.37
Upside: +37.68%
MeiraGTx Holdings
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $7.89
Upside: +153.49%
Cartesian Therapeutics
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $7.44
Upside: +303.23%
Neurogene
Nov 13, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $19.28
Upside: +263.07%
Korro Bio
Nov 13, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.94
Upside: -
CytomX Therapeutics
Nov 11, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $3.97
Upside: +152.21%
Intellia Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $8.93
Upside: +67.97%
Ionis Pharmaceuticals
Nov 10, 2025
Maintains: Buy
Price Target: $100 → $110
Current: $77.57
Upside: +41.81%
BioMarin Pharmaceutical
Oct 27, 2025
Maintains: Neutral
Price Target: $60 → $55
Current: $52.05
Upside: +5.67%
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $6.88
Upside: +190.70%
Oct 27, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $28.45
Upside: +40.60%
Oct 21, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.67
Upside: +34.44%
Oct 21, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $17.23
Upside: +132.15%
Oct 17, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $21.36
Upside: +180.90%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $55.39
Upside: +44.43%
Sep 17, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $19.46
Upside: +28.47%
Sep 11, 2025
Reiterates: Buy
Price Target: $125
Current: $11.03
Upside: +1,033.79%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.36
Upside: +111.86%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $13.05
Upside: +91.57%
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $20.84
Upside: -76.01%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $22.68
Upside: +32.28%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.69
Upside: +314.20%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $4.37
Upside: -54.23%
Aug 14, 2025
Reiterates: Buy
Price Target: $14
Current: $11.03
Upside: +26.93%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.20
Upside: +233.33%